Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide(CAS: 1105067-87-5)

Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide (CAS: 1105067-87-5) falls under regulatory guidelines such as the REACH regulations for chemical substances, FDA requirements for pharmaceuticals, and EPA guidelines for environmental handling. These regulations cover safety data sheets, risk assessment, and proper disposal methods.

Synthetic alternatives to Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide include similar statins like Simvastatin or Pravastatin. Alternative reagents and processes can also be used in synthesis, but they may require different handling and regulatory considerations.

Research trends for Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide (CAS: 1105067-87-5) are focusing on improving its efficacy and exploring its potential in combination therapies. Market-wise, there is a growing interest in cost-effectiveness and sustainability, driven by increasing awareness of cardiovascular diseases.

Waste containing Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide (CAS: 1105067-87-5) should be collected in sealed containers and disposed of through professional waste disposal services. Proper incineration and environmental protection measures should be taken to ensure compliance with regulatory guidelines.